Here, we identified a previously unreported therapeutic strategy to reduce CD47 expression by LAT2 inhibition and underscore the potential of LAT2 small-molecular inhibitors, such as BCH, in elimination of CD47-mediated tumor evasion. This evidence concerns the gene LAT2 and neoplasm.